The proposed protocol is an 8 week open label outpatient pilot trial of the safety and
efficacy of pregabalin (Lyrica) in the treatment of alcohol use disorder. The primary
objective of the study is to determine the efficacy of pregabalin in promoting alcohol
abstinence among individuals with an alcohol use disorder.